Product NDC: | 0548-3369 |
Proprietary Name: | Naloxone Hydrochloride |
Non Proprietary Name: | Naloxone Hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; Naloxone Hydrochloride |
Administration Route(s): | PARENTERAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0548-3369 |
Labeler Name: | Amphastar Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072076 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010601 |
Package NDC: | 0548-3369-00 |
Package Description: | 1 SYRINGE in 1 CARTON (0548-3369-00) > 2 mL in 1 SYRINGE |
NDC Code | 0548-3369-00 |
Proprietary Name | Naloxone Hydrochloride |
Package Description | 1 SYRINGE in 1 CARTON (0548-3369-00) > 2 mL in 1 SYRINGE |
Product NDC | 0548-3369 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Naloxone Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | PARENTERAL |
Start Marketing Date | 20010601 |
Marketing Category Name | ANDA |
Labeler Name | Amphastar Pharmaceuticals, Inc. |
Substance Name | NALOXONE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |